SNBCare

Nasal Esketamine: Treatment-Resistant Depression Therapy for Adults

Nasal esketamine offers an FDA-cleared treatment option for adults living with treatment-resistant depression (TRD), especially when traditional antidepressants have not provided adequate relief. Because licensed providers administer the treatment under close clinical supervision, patients receive structured, support throughout the process for MDD or TRD. Additionally, licensed providers at SNBCare in Massachusetts and Rhode Island offer […]

Esketamine in Massachusetts: Advanced Treatment for Adults With Depression

Esketamine in Massachusetts refers to REMS-compliant Spravato® treatment available to adults with treatment-resistant depression (TRD). Esketamine represents a newer, rapid-acting therapeutic option for individuals whose depression has not adequately improved after multiple trials of traditional antidepressants. At SNBCare, adults in Massachusetts can access certified esketamine providers, integrated with behavioral health support, therapy, and psychiatric care, […]